APA (7th ed.) Citation

O, M., MB, S., TR, H., & JS, S. (2023). Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms. Best practice & research. Clinical endocrinology & metabolism, 37(5), 101796. https://doi.org/10.1016/j.beem.2023.101796

Chicago Style (17th ed.) Citation

O, Mosalem, Sonbol MB, Halfdanarson TR, and Starr JS. "Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms." Best Practice & Research. Clinical Endocrinology & Metabolism 37, no. 5 (2023): 101796. https://doi.org/10.1016/j.beem.2023.101796.

MLA (9th ed.) Citation

O, Mosalem, et al. "Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms." Best Practice & Research. Clinical Endocrinology & Metabolism, vol. 37, no. 5, 2023, p. 101796, https://doi.org/10.1016/j.beem.2023.101796.